U.S. Markets closed

Delcath Systems, Inc. (DCTH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0565-0.0233 (-29.1980%)
At close: 3:59PM EDT
People also watch
DXTRCYTRAVEOCLSNIDXG
  • P
    Patricia
    Patricia
    Why did they even have us vote if they could go around us anyway?
  • E
    Elias`
    Elias`
    Go Ahead and call me a fool but I truly believe that there is a light at the end of this dark tunnel.
    Why else are they in so many hospitals in the USA with clinical trials eventually leading to FDA FASTRACK?
    I also believe that RS was needed as part of deal before Partnership or possible Merger can move forward.
    Why Delete Twitter Posts few months ago?
    Why Quiet Period?
    I think as it has been proven that Jennifer is smarter than all of us. (Bulls & Bears)
    Therefore I am STILL BULLISH!
    Scared money don't make money &
    You only lost if you sold.
    I call it weathering the storm!
  • S
    SK6
    SK6
    I feel like a child being punished. She blames the lack of available capital on shareholders for not approving a reverse split. But in actuality, she should be blaming herself and the board for mismanagement. The reverse split is manipulation at its finest: inflate a stock price by reducing the upside potential of your shareholders investment. You know increases a stock price? Intelligently managing the company, keeping investors aware of milestones and not overpaying executives. This is a joke.
  • N
    Neutron Solstice
    Neutron Solstice
    That 500,000 dollars convertible note goes straight to Jenny's salary.
  • N
    Neutron Solstice
    Neutron Solstice
    Should be a crime what this board did to the DCTH shareholders.
  • N
    Neutron Solstice
    Neutron Solstice
    That CEO completely circumvented shareholders wishes.
  • T
    The Invisible Hand
    The Invisible Hand
    the ceo is getting her paycheck at shareholders expense. this is a team of incompetence. why isnt the ceo shown the door out! companies that have MC three times of DCTH and have revenue streams dont get paid as much as she does. and if the news from Europe was so good, why the heck they fall short in PR effect. i sold mine taking 3K in losses. i will buy back once this hits below 0.01 and i think it is going to happen. feel sorry for the longs. Investing should not be done with the heart.
  • J
    Jack
    Jack
    The central question that management should clarify is, how have they moved the clinical goalpost forward these past several years with all the monies already raised through two previous reverse splits and from ongoing massive stock sales and dilution. For all this, after all these years, I see management still issuing statements like - We have 'commenced' a global Phase 3 FOCUS clinical trial, or have 'plans' to initiate a global registration trial for ICC.' Huh? Have commenced, have plans to ... still? I don't get it. Maybe someone can explain.
  • P
    Patricia
    Patricia
    No buying opportunity here, most likely after split it heads right back down just like it did twice before. But the company paychecks keep on flowing.
  • E
    Elias`
    Elias`
    Don't Listen to Bashers and Shorts!
    They want you to sell so they can profit!
    The Fundamentals of the CHEMOSAT have not changed but only got better and with each day we move forward closer to FDA.
    Just wanted to say, Don't sell for a heavy loss because this can turn around fast when positive results come out. Hopefully soon!
    God help us all, especially the patients that are able to live longer because of CHEMOSAT.
    I am Going to Stay Long and see how this plays out.
    Not a pumper, im not telling you to buy but I Believe.
  • T
    Turk
    Turk
    Looks like Jen's wrath is about to begin:

    Item 1.01 Entry into a Material Definitive Agreement.
    On September 12, 2017, our Board authorized the establishment of a new series of preferred stock designated as Series C Preferred Stock, $0.01 par value, the terms of which are set forth in the certificate of designations for such series of Preferred Stock (the “Series C Certificate of Designations”) which was filed with the State of Delaware on September 20, 2017 (together with any preferred shares issued in replacement thereof in accordance with the terms thereof, the “Series C Preferred Stock”). On September 21, 2017, we entered into a securities purchase agreement (the “SPA”) with two of our investors which had purchased certain senior secured convertible notes (the “Notes”), convertible into shares of our common stock pursuant to a certain June 6, 2016 securities purchase agreement, of $0.5 million aggregate purchase price for 590 shares of Series C Preferred Stock (the “Series C Preferred Shares”). The purchase of the Series C Preferred Stock is being made in reliance upon the exemption from registration provided by Rule 4(a)(2) of the Securities Act of 1933, as amended. The Series C Preferred Shares shall be entitled to 519,421,250 votes and may only vote on approval of a reverse split of our outstanding common stock. The Series C Preferred Stock has no dividend, liquidation or other preferential rights to our common stock, and each share of Series C Preferred Stock shall be redeemable for the amount of $1,000.00, payable in cash, per share at our written election, and must be redeemed by us no later than December 21, 2017.
  • N
    Neutron Solstice
    Neutron Solstice
    Everybody says this is a great product. My ? is has it been a great product since 1988? And now that there OTC can they do a R/S without a vote I wonder?
  • E
    Elias`
    Elias`
    No One Here Absolutely knows what is coming next. If they truly did they wouldn't be here.
    They all just like playing mind games.
    Step away and clear your mind before making any rational decisions.
    Don't let anyone, including me clutter your mind.
    Do you DD and trust only your instincts!
  • T
    Turk
    Turk
    so, will it be 1:50, 1:100, or 1:350. 1:100 makes the most sense to me. that leaves current equity 1% (5mln shares) and the company gets to restock the coffer with 495 min new shares to sell.
  • N
    Neutron Solstice
    Neutron Solstice
    Money doesn't care about emotions. Buyer beware.
  • N
    Neutron Solstice
    Neutron Solstice
    Some people are cultishly crazy in supporting this stock that only had enough money to go 2 more months. How much lifeline does 500,000 dollars give them I wonder? ya know Jim Jones had a cult to but you dint see me buying up any Flavor-Aid stock
    Imagewolf-lundgren
  • C
    Captain
    Captain
    I smell a class action in the wind
  • J
    June
    June

    Harold Koplewicz, M.D. resigned as a member of the Board of Directors of Delcath Systems, Inc. (the “Company”), effective September 15, 2017. http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-secText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExODA1NTUyJkRTRVE9MSZTRVE9JlNRREVTQz1TRUNUSU9OX0JPRFkmZXhwPSZzdWJzaWQ9NTc%3d

  • B
    Bearsfan#1
    Bearsfan#1
    Ya'll. We have to believe in the company that we are investing in. Many of my buddies say I am dumb for continuing to support this company. I don't care what they say because I believe they have a great product. For all the believers hold because good things come to those that wait.
  • m
    michael
    michael
    I must agree on this point. Why should I vote when they just do It anyway